肝细胞癌
转移
小RNA
癌症研究
蛋白激酶B
PI3K/AKT/mTOR通路
信号转导
生物
医学
内科学
癌症
细胞生物学
基因
生物化学
作者
Jingsong Chen,LI Hua-shu,Jiongqiang Huang,Shihao Dong,Zhijie Huang,Wei Yi,Gao-fang Zhan,Ju-Tao Feng,Jiancong Sun,Xiaohui Huang
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2016-03-02
卷期号:375 (1): 73-83
被引量:103
标识
DOI:10.1016/j.canlet.2016.02.043
摘要
Some microRNAs (miRNAs) have been implicated in hepatocellular carcinoma (HCC) development and progression. However, the roles and mechanisms of several miRNAs in HCC remain poorly understood. Here, we report that miR-379-5p, which is down-regulated in HCC tissues and cell lines, is associated with advanced TNM stage and metastasis in HCC. The ectopic overexpression of miR-379-5p inhibited HCC cell migration, invasion, epithelial-to-mesenchymal transition (EMT) and metastasis both in vitro and in vivo. Conversely, miR-379 knockdown increased migration, invasion and EMT in HCC cells. Moreover, miR-379-5p exerted this function by directly targeting focal adhesion kinase (FAK) 3'-UTR and repressing FAK expression, thus leading to suppression of AKT signaling. Furthermore, the tumor suppressive effects of miR-379-5p in HCC cells were reversed by activating AKT signaling or restoring FAK expression. In clinical samples of HCC, miR-379-5p negatively correlated with FAK, which was up-regulated in HCC. Taken together, our findings highlight the important role of miR-379-5p in regulating the EMT and metastasis of HCC by targeting FAK/AKT signaling, suggesting that miR-379-5p may represent a novel potential therapeutic target and prognostic marker for HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI